Details of the Drug

General Information of Drug (ID: DM1O7PR)

• Drug Name: Peptide-T
• Synonyms: Peptide T; Peptide-T, Carlbiotech; Peptide-T, Peptech

Indication

Disease Entry	ICD 11	Status	REF
Neurodegenerative disorder	8A20-8A23	Phase 2	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C35H55N9O16
  Canonical SMILES: CC(C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CO)NC(=O)C(C)N)O
  InChI: InChI=1S/C35H55N9O16/c1-13(36)28(52)40-22(12-45)31(55)41-25(15(3)47)33(57)43-26(16(4)48)34(58)42-24(14(2)46)32(56)39-21(11-23(37)51)29(53)38-20(10-18-6-8-19(50)9-7-18)30(54)44-27(17(5)49)35(59)60/h6-9,13-17,20-22,24-27,45-50H,10-12,36H2,1-5H3,(H2,37,51)(H,38,53)(H,39,56)(H,40,52)(H,41,55)(H,42,58)(H,43,57)(H,44,54)(H,59,60)/t13-,14+,15+,16+,17+,20-,21-,22-,24-,25-,26-,27-/m0/s1
  InChIKey: IWHCAJPPWOMXNW-LYKMMFCUSA-N
• Cross-matching ID:
  PubChem CID: 73352
  CAS Number: 106362-32-7
  TTD ID: D0W4VH

References

• [1] ClinicalTrials.gov (NCT00000392) Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.. U.S. National Institutes of Health.